scholarly journals Online seminars as an information source for direct-to-consumer stem cell therapy

2021 ◽  
Author(s):  
Mirna Hassoun ◽  
Sidney Golub ◽  
Sheldon Greenfield ◽  
Joshua D Grill ◽  
Brian J Cummings
Keyword(s):  
Stem Cell ◽  
Cell Therapy ◽  
Stem Cell Therapy ◽  
Clinical Evidence ◽  
Scientific Evidence ◽  
Information Source ◽  
The Internet ◽  
Regulatory Oversight ◽  
Direct To Consumer

Aim: To attend stem-cell (SC) seminars hosted by US-based direct-to-consumer SC businesses either in person or via online ‘webinars’ to determine accuracy and regulatory oversight of the advertised SC therapies. Methods: The therapeutic claims, costs, risks, scientific evidence in support of a therapy and any regulatory oversight were collated using pre-established checklists. Participation consisted of one live attendance of a seminar, and following COVID-19 restrictions, review of seven recorded presentations available on the internet from SC businesses. Results & conclusion: None of the SC therapies advertised by direct-to-consumer clinics reviewed were supported by proper clinical evidence nor substantiated by peer reviewed literature.

Online Direct-to-Consumer Advertising of Stem Cell Therapy for Musculoskeletal Injury and Disease

2020 ◽  
Vol 102 (1) ◽  
pp. 2-9 ◽  
Author(s):  
Matthew T. Kingery ◽  
Lauren Schoof ◽  
Eric J. Strauss ◽  
Joseph A. Bosco ◽  
Joanne Halbrecht
Keyword(s):  
Stem Cell ◽  
Cell Therapy ◽  
Stem Cell Therapy ◽  
Musculoskeletal Injury ◽  
Direct To Consumer ◽  
Direct To Consumer Advertising

Stem Cell Therapy, Ophthalmic Applications, and the Current Controversies With Direct-to-Consumer Marketing

2020 ◽  
Vol 60 (4) ◽  
pp. 179-192
Author(s):  
Jodi C. Hwang ◽  
Patrick C. Staropoli ◽  
Ajay E. Kuriyan ◽  
Nicolas A. Yannuzzi ◽  
Jayanth Sridhar
Keyword(s):  
Stem Cell ◽  
Cell Therapy ◽  
Stem Cell Therapy ◽  
Direct To Consumer ◽  
Consumer Marketing

scholarly journals Cross-Culture Online Knowledge Validation and the Exclusive Practice of Stem Cell Therapy

2021 ◽  
Vol 29 (2) ◽  
pp. 1-28
Author(s):  
Abrar Al-Hasan ◽  
Jiban Khuntia ◽  
Dobin Yim
Keyword(s):  
Stem Cell ◽  
Cell Therapy ◽  
Cord Blood ◽  
Umbilical Cord ◽  
Stem Cell Therapy ◽  
Umbilical Cord Blood ◽  
Theoretical Perspective ◽  
The Internet ◽  
Cross Culture ◽  
Knowledge Validation

Increasingly, people are turning to the internet to access health information despite reports that sites vary in terms of their quality, especially when the health practice is emerging or exclusive, such as stem cell and umbilical cord blood therapy. Given the controversy, patients have to depend on available sources to validate their knowledge prior to going for these practices as treatments. This study explores how the internet supports the spread of stem cell therapy practices, viewing it from a knowledge validation theoretical perspective. The study posits hypotheses differentiating digital and human sources, trust in the media source, and exploratory and verification sources on knowledge validation for exclusive practices. Primary survey data was collected from the US and Kuwait. Key findings suggest that knowledge verification and trust in the internet influences knowledge conversion and the practice decision of patients for less practice-oriented knowledge, and this effect is higher for Kuwait than USA, and more so for stem cell than umbilical cord blood practice.

Stem Cells and Tissue Engineering in Medical Practice: Ethical and Regulatory Policies

2019 ◽  
Vol 20 (4) ◽  
pp. 388-398 ◽  
Author(s):  
Rakesh Sharma
Keyword(s):  
Tissue Engineering ◽  
Stem Cells ◽  
Stem Cell ◽  
Cell Therapy ◽  
Stem Cell Therapy ◽  
Stem Cell Research ◽  
Current Knowledge ◽  
Treatment Options ◽  
Regulatory Oversight ◽  
Regulatory Policies

Stem Cell Research and Tissue Engineering, in present time, have emerged as a legalized and regulated stem cell treatment option globally, but scientifically, their success is unestablished. Novel stem cell-based therapies have evolved as innovative and routine clinical solutions by commercial companies and hospitals across the world. Such rampant spread of stem cell clinics throughout UK, US, Europe and Asia reflect the public encouragement of benefits to incurable diseases. However, ever growing stem cell therapy developments need constant dogwatch and careful policy making by government regulatory bodies for prompt action in case of any untoward public concern. Therefore, researchers and physicians must keep themselves abreast of current knowledge on stem cells, tissue engineering devices in treatment and its safe legal limits. With this aim, stem cell scienctific developments, treatment options and legal scenario are introduced here to beginner or actively inolved scientists and physicians. Introduction to stem cell therapy will provide basic information to beginner researchers and practice physicians on engineered stem cell research concepts and present stem cell therapy federal regulations in different North American, European and Asian countries. FDA, CDC, EU, ICMR government policies in different countries include information on the current legal position, ethical policies, regulatory oversight and relevant laws.

Sign in / Sign up

Export Citation Format

Share Document